Integrated Diagnostics announced this week that Kenneth Fang will be its new chief medical officer and VP of translational research and clinical development. In this position, Fang will lead the development of diagnostics for the early detection of complex diseases, such as lung cancer and Alzheimer’s disease. Previously, Fang served as senior director for clinical development at XDx and was on the faculty at University of California - San Francisco.
23andMe this week announced it has formed an Independent Sarcoma Scientific Advisory Committee. In the committee, 23andMe has appointed Robert Maki, a medical oncologist and co-leader of the adult sarcoma disease management team at Memorial Sloan-Kettering Cancer Cetner; George Demetri, director of Dana-Farber Cancer Institute's Center for Sarcoma and Bone Oncology; Judy Garber, co-director of the Friends of Dana-Farber Cancer Genetics and Prevention Program; and Mark Robson, clinic director, of Sloan-Kettering's Clinical Genetics Service; and others.